Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tretinoin (Cordes VAS) for actinic keratosis
2007-000093-23Phase 2Completed
- Sponsor
- Almirall
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tretinoin in actinic keratosis (AK), sponsored by Almirall. Primary endpoint: Improvement of actinic lesions by clinical grading. Started Jul 2009; status: completed.
02
Drugs
tretinoin
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2007-000093-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000093-23.